CM
GPCR icon

Caption Management’s Structure Therapeutics GPCR Stock Holding History

Caption Management’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-185,200
Closed -$5.19M – 1768
2025
Q3 		$5.19M Buy
185,200
+150,200
+429% +$2.99M 0.04% 479
2025
Q2 		$726K Buy
35,000
+21,100
+152% +$464K 0.01% 1022
2025
Q1 		$241K Sell
13,900
-6,500
-32% -$159K ﹤0.01% 1242
2024
Q4 		$553K Hold
20,400
– – 0.01% 1081
2024
Q3 		$895K Sell
20,400
-52,100
-72% -$2.01M 0.01% 809
2024
Q2 		$2.85M Sell
72,500
-40,000
-36% -$1.64M 0.04% 405
2024
Q1 		$4.82M Sell
112,500
-536,300
-83% -$22.6M 0.07% 306
2023
Q4 		$26.4M Buy
+648,800
New +$37.2M 0.36% 54

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Caption Management's GPCR Position: Q4 2025 in Review

Caption Management sold out of Structure Therapeutics (GPCR) in Q4 2025, closing a stake of 56,682 shares — an estimated $1.59M sold.

Caption Management first reported a position in GPCR in Q1 2024 and held it in 7 quarters. The position peaked at $3M in Q1 2024. 197 funds tracked by Wall St. Rank hold GPCR as of Q4 2025.

  • Caption Management reported no remaining Structure Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Caption Management sold 56,682 Structure Therapeutics shares in Q4 2025, an estimated $1.59M.
  • Caption Management first reported a position in Structure Therapeutics in Q1 2024 and held it in 7 quarters.
  • Caption Management's Structure Therapeutics position peaked at $3M in Q1 2024.
  • 197 funds tracked by Wall St. Rank held Structure Therapeutics as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.